Gyre Therapeutics Inc.
GYRE | NASDAQ
$4.88
+$0.33 (+7.14%)
Nov 2, 2026, 10:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -22.99M | -8.69M | -2.4M | 5.94M | 1.58M | 3.73M | 569K | 1.12M | 3.53M | 9.94M | -100.98M | 7.51M | 3.77M | 2.24M | -40.45M | -4.88M | 51.63M | 7.93M | -20.33M | -25.24M | -19.93M | -22.44M |
Depreciation & Amortization | 1.48M | 672K | 656K | 649K | 641K | 535K | 471K | 454K | 238K | 415K | 308K | 202K | 318K | 286K | 10K | 40K | 67K | 489.17K | 115K | 85K | 45K | 45K |
Stock-Based Compensation | 2.08M | n/a | 4.6M | 1.15M | 906K | 507K | 567K | n/a | n/a | 11K | 7.28M | n/a | n/a | n/a | n/a | n/a | n/a | 640.96K | n/a | 713K | 983K | 1.03M |
Other Working Capital | 5.72M | -85K | 1.85M | -1.82M | 3.32M | -3.34M | 2.16M | -781K | -3.33M | -2.07M | 2.34M | -587K | 1.11M | 1.36M | 3.68M | -1.77M | -3.99M | 972.52K | -4K | -45K | 864K | -2.33M |
Other Non-Cash Items | -431K | 2.42M | 159K | -72K | -446K | -1.37M | -152K | 2.02M | -1.9M | -4.41M | 95.68M | 689K | 18K | 2.26M | 83.17M | 334K | -56.9M | -904.26K | 683K | n/a | n/a | n/a |
Deferred Income Tax | -1.43M | -738K | 831K | -531K | -300K | -191K | -592K | n/a | -97K | -313K | -403K | -199K | -230K | -328K | -838K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.56M | 9.51M | -9.47M | -2.45M | -289K | -3.35M | -3.62M | -1.93M | -7.39M | -2.76M | 1.47M | -620K | 657K | 5.95M | 406K | -2.77M | -7.09M | 838.2K | 1.86M | 2.84M | -1.22M | -2.99M |
Operating Cash Flow | -16.73M | 3.18M | -5.63M | 4.68M | 2.09M | -129K | -2.76M | 1.68M | -5.61M | 2.88M | 3.36M | 7.58M | 4.53M | 10.42M | 42.3M | -7.28M | -12.29M | 9M | -17.68M | -21.6M | -20.12M | -24.36M |
Capital Expenditures | -1.29M | -178K | -144K | -683K | -279K | -821K | -745K | -693K | -1.46M | -231K | -2.33M | -1.98M | -2.48M | -1.74M | -2.41M | n/a | -2.58M | -3.12M | n/a | -492K | -347K | n/a |
Cash Acquisitions | n/a | 6K | n/a | n/a | n/a | n/a | n/a | -5K | 218K | n/a | 5.02M | n/a | n/a | n/a | -55.45M | n/a | 55.45M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.96M | -12.95M | -2.22M | -564K | -2.78M | -8.4M | -1.4M | -1.69M | -14.07M | -7.04M | -1.4M | -2.79M | -5.71M | n/a | -1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 15.99M | 10.07M | 4.24M | n/a | n/a | 11.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5M | n/a | n/a | n/a | 2.87M | 7.53M | 11.05M | 27.58M |
Other Investing Acitivies | -1.02M | n/a | -30K | -15K | -5K | -698K | -672K | n/a | 7.04M | 50K | 42K | -639K | 133K | -5.84M | -7.48M | n/a | n/a | -2.54M | n/a | n/a | n/a | n/a |
Investing Cash Flow | 9.76M | -3.06M | 1.85M | -1.25M | -3.04M | 1.97M | -2M | -2.39M | -8.27M | -7.22M | 1.34M | -5.4M | -8.05M | -7.65M | -69.19M | n/a | 52.87M | -3.12M | 2.87M | 7.04M | 10.7M | 27.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -114.19K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45.03M | -45.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -208K | n/a | n/a | 365K | -649K | 835K | 964K | n/a | n/a | 658K | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | -13.68K | n/a | n/a | n/a | n/a |
Financial Cash Flow | -8K | 21K | 318K | 365K | 22.35M | 1.34M | 964K | 374K | 275K | 658K | 2.5M | n/a | n/a | n/a | 45.01M | -45.03M | -121.56K | -127.88K | n/a | 98K | -4K | 49.46M |
Net Cash Flow | 5.79M | 431K | -3.33M | 3.91M | 21.45M | 3.23M | -4.05M | -231K | -13.69M | -3.72M | 7.43M | 2.35M | -4.42M | -13.57M | 2.09M | -52.3M | 40.58M | 5.75M | -14.81M | -14.46M | -9.42M | 52.68M |
Free Cash Flow | -18.01M | 3M | -5.77M | 3.99M | 1.81M | -950K | -3.5M | 983K | -7.07M | 2.65M | 1.04M | 5.61M | 2.06M | 8.68M | 39.89M | -7.28M | -14.87M | 5.87M | -17.68M | -22.09M | -20.47M | -24.36M |
Adj. Free Cash Flow | -20.09M | 3M | -10.37M | 2.85M | 903K | -1.46M | -4.07M | 983K | -7.07M | 2.64M | -6.25M | 5.61M | 2.06M | 8.68M | 39.89M | -7.28M | -14.87M | 5.23M | -17.68M | -22.81M | -21.45M | -25.38M |
Maintenance CapEx | -1.29M | -178K | n/a | n/a | n/a | -821K | -586.77K | -693K | -1.46M | n/a | -2.33M | -1.38M | n/a | n/a | n/a | n/a | -2.58M | -3.12M | n/a | -44.44K | -347K | n/a |
Growth CapEx | n/a | n/a | -144K | -683K | -279K | n/a | -158.23K | n/a | n/a | -231K | n/a | -598K | -2.48M | -1.74M | -2.41M | n/a | n/a | n/a | n/a | -447.56K | n/a | n/a |
Owner Earnings | -18.01M | 3M | -5.63M | 4.68M | 2.09M | -950K | -3.34M | 983K | -7.07M | 2.88M | 1.04M | 6.2M | 4.53M | 10.42M | 42.3M | -7.28M | -14.87M | 5.87M | -17.68M | -21.64M | -20.47M | -24.36M |
Add to Watchlist
Select watchlists to add or remove GYRE